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Glomerular interleukin 1 production is dependent on
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Glomerular interleukin 1 production is dependent on macrophage inifi-
tration in anti-GBM glomerulonephritis. Both macrophages and glomerular
mesangial cells have the potential to synthesize interleukin I (IL-i),
however, their respective contributions to IL-i production in anti-GBM
glomerulonephritis (GN) are unknown. To address this problem, IL-i
production by glomeruli from rabbits with macrophage-associated anti-
GBM GN (passive autologous anti-GBM GN EPAGBMGNI) and macro-
phage independent (heterologous phase) anti-GBM GN was studied.
Macrophage-infiltrated nephritic glomeruli produced IL-i bioactivity
which was inhibitable by an anti-IL-I antibody, and had a molecular
weight consistent with rabbit IL-l. Glomerular IL-l production in
PAGBMGN was markedly augmented (1.43 0.79 U/103 glomeruli
[glomsl/24 hr) compared to normal glomeruli (0.13 0.06 U/b3 gloms/24
hr, P < 0.05) or glomeruli from rabbits with macrophage independent GN
(0.11 0.07 U/l03 gloms/24 hr, P < 0.05). IL-i production by glomeruli
from leukocyte depleted rabbits with PAGBMGN (0.16 0.07 U/b3
gloms/24 hr) was not significantly elevated compared to normal glomeruli.
Glomerular macrophages from rabbits with PAGBMGN produced more
IL-I (3.62 1.63 U/103 cells/24 hr) than blood monocytes (0.51 0.30
U/b3 cells/24 hr) or alveolar macrophages (0.24 0.12 U/b3 cells/24 hr)
from the same animals. These results show that in experimental anti-GBM
GN where injury is macrophage dependent, IL-i production is also
macrophage dependent and infiltrating glomerular macrophages are the
major source of IL-i. Further, as glomerular IL-l production was not
significantly augmented in GN in the absence of macrophages, giomerular
deposition of immunoglobulin and complement alone do not stimulate
significant IL-l production by intrinsic glomerular cells in experimental
anti-GBM GN.
Interleukin 1 (IL-i) is an important inflammatory mediator
produced by macrophages [1—3], endothelial cells [4] and gb-
merular mesangial cells [5, 6]. It has the capacity to stimulate
polymorphonuclear leukocyte chemotaxis [7], to stimulate pro-
liferation [8], and eicosanoid production [9] by mesangial cells,
to enhance procoagulant expression by endothelial cells [10,
ii], and to act as a co-mitogen for T cells [6, 12]. Infusion of
IL-i has also been shown to increase proteinuria of rats
developing anti-glomerular basement membrane antibody-in-
duced glomerulonephritis (anti-GBM GN) [13]. These capaci-
ties give IL-i the potential to be an important mediator of injury
in glomerulonephritis (GN).
IL-i bioactivity has been detected in supernatants from
nephritic glomeruli of rabbits developing anti-GBM GN [14],
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from rats with focal and segmental glomerulosclerosis [i5] and
nephrotoxic serum nephritis [16], and from patients with rapidly
progressive crescentic GN [17]. Messenger RNA for IL-i is
expressed both in glomerular mesangial cells and glomerular
macrophages from mice with spontaneous GN [18], and in
mesangial cells from rats with a non-proliferative model of
immune complex GN [i9]. The relative contributions of infil-
trating macrophages and intrinsic glomerular cells to glomerular
IL-i production in macrophage dependent GN is unknown.
In the current studies, IL-i production by isolated glomeruli
from rabbits with a proliferative model of GN (passive autolo-
gous anti-GBM GN [PAGBMGN]), with prominent glomerular
macrophage infiltration, was quantified and characterized by
biological activity, molecular weight and inhibition with an
anti-IL-l antibody. IL-i production by glomeruli in this disease
was compared to glomerular production of IL-i in a macro-
phage independent model (heterologous phase anti-GBM GN)
and the effect of macrophage depletion on glomerular IL- 1
production was studied. The IL-i production by glomerular
macrophages isolated from rabbits with PAGBMGN was com-
pared to the production of IL-i by blood monocytes and
alveolar macrophages from the same animals.
Methods
induction of passive autologous anti-glomerular basement
membrane antibody-induced glomerulonephritis (PAGBMGN)
Sheep anti-rabbit GBM antibody was prepared by repeated
immunization of a sheep with purified GBM in Freund's com-
plete adjuvant (FCA, Commonwealth Serum Laboratories
[CSL], Parkvilie, Victoria, Australia) as previously described
[20]. The sheep serum was absorbed against rabbit erythrocytes
and administered as a globulin fraction. The autologous anti-
sheep globulin serum was obtained by repeated immunization
of rabbits with purified sheep gamma-globulin in FCA. The
serum was pooled and a globulin fraction was prepared.
PAGBMGN was initiated as previously described [21] by
intravenous (i.v.) injection of sheep anti-rabbit GBM globulin at
a dose of 48 mg/kg, which resulted in a mean binding of 73.76
10.5 g of specific kidney-fixing antibody per gram wet weight
of kidney by the paired label technique [22]. This was followed
i6 hours later by three i.v. injections of rabbit anti-sheep
globulin (75 mg/kg) at intervals of 8 and 16 hours between the
first and second and second and third doses, respectively.
Animals were sacrificed four hours after the last dose of this
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passively-administered autologous antibody (44 hours after
initiation of the model).
Induction of heterologous phase anti-glomerular basement
membrane antibody-induced glomerulonephritis
(anti-GBM GN)
This form of anti-GBM GN was induced by the i.v. injection
of two doses of sheep anti-rabbit GBM globulin (48 mg/kg)
given at an interval of 24 hours. Renal tissues from these rabbits
were assessed at two times: at 24 hours (just prior to the second
antibody dose) and at 44 hours after the initial dose of antibody.
This model of glomerular injury is dependent on neutrophils and
complement and is macrophage independent [211; at 44 hours
the period for development of injury is the same as for the
macrophage dependent PAGBMGN model.
Isolation and culture of glomeruli
Renal cortical tissue was aseptically collected into tissue
culture medium (Eagles Minimal Essential Medium, CSL)
containing 10% fetal calf serum (FCS, CSL). This culture
medium was used for all glomerular and macrophage cultures.
Isolated glomeruli were prepared under sterile conditions by a
graded sieving technique [20, 231 to obtain approximately i05
glomeruli, with less than 5% contamination by tubular frag-
ments (assessed by phase contrast microscopy). Glomeruli
were then cultured in 75 cm2 polystyrene tissue culture flasks
(Sterilin, Teddington, Middlesex, UK) at 37°C in a 5% C02/air
humidified atmosphere, at a concentration of 4 x l0 glomeruli
per ml. After culture, medium was centrifuged at 3000 rpm for
five minutes to remove glomeruli and the supernatant stored at
—70°C. The endotoxin content of culture supernatants was
measured using the Limulus Amebocyte Lysate assay (Whit-
taker MA Bioproducts, mc, Walkersville, Maryland, USA) and
was less than 0.05 ng/ml.
Isolation and culture of glomerular macrophages
Glomeruli from rabbits with PAGBMGN were isolated as
above and cultured in polystyrene tissue culture flasks (Sterilin)
for one hour, to allow emigration of macrophages from glomer-
uli and adherence to the plastic tissue culture surface as
previously described [24, 25]. Glomeruli were removed from
the flasks by decanting the culture medium after vigorous
agitation, and washing twice with warm culture medium. The
adherent glomerular macrophages (approximately i05 cells)
were then incubated with 10 ml of fresh medium for a further 24
hours. At the end of this period, the culture medium was
centrifuged and stored at —70°C. Adherent macrophages were
removed by incubation for three minutes with trypsin-versene
(CSL) and counted using a hemocytometer. This technique
harvests 4.4 1.9% of glomerular macrophages. These cells
have previously been characterized by adherence, esterase
staining, phagocytosis, Fc binding and mononuclear morphol-
ogy [24, 25].
Isolation and culture of peripheral blood monocytes (PBM)
Fifty milliliters of heparinized blood was collected aseptically
from each rabbit at the same time as renal tissue was taken.
Mononuclear cells were isolated by the method of BØyum [26].
Blood was mixed with an equal quantity of saline and layered
onto dextran/sodium metrizoate (Lympho-paque, Nyegaard
Diagnostica, Oslo, Norway). After centrifugation at 800 g for 20
minutes, the mononuclear cell layer was aspirated, resuspended
in culture medium and washed once. The cells were then
cultured in polystyrene tissue culture flasks (Sterilin) at 37°C in
a 5% C02/air humidified atmosphere for one hour. After this
period, the flasks were agitated vigorously and washed twice
with warm culture medium to remove non-adherent cells. The
incubation of the adherent cells was then continued for 24
hours. Culture supernatants were obtained by centrifugation
and were stored at —70°C. Adherent cells were removed by
three minutes exposure to trypsin-versene and counted using a
hemocytometer.
Isolation and culture of pulmonary alveolar macrophages
(PAM)
After collection of blood and renal tissue from rabbits,
bronchoalveolar lavage was performed by the endotracheal
instillation and subsequent aspiration of 50 ml of sterile normal
saline. Cells were washed in sterile culture medium and cul-
tured in an identical manner to the PBM cells. Cell cultures
were centrifuged at 3000 rpm for five minutes and the superna-
tants stored at —70°C. The cell numbers were determined as for
PBM cells.
Interleukin 1 (IL-i) bioassay
IL-I bioactivity in culture supernatants was determined using
the method of Mizel, Oppenheim and Rosenstreich [12]. A
single cell suspension of thymocytes from 5 to 7 week old
C3H/HeJ mice was prepared by gently teasing the thymus in
RPMI 1640 culture medium (CSL). Aggregates were removed
by five minutes of gravity sedimentation. The cells were washed
once and resuspended in RPMI 1640 containing 10% FCS (CSL)
and 2.5 x l05M 2-mercaptoethanol (BDH Chemicals, Poole,
UK). Thymocytes (1 x 106 per well) were incubated in flat-
bottom microtiter plates (Flow Laboratories, Melbourne, Aus-
tralia) in the presence of 1 g/ml phytohemagglutinin (PHA,
Wellcome Diagnostics, Dartford, UK) and either culture super-
natant at an appropriate dilution or purified cell line-derived
human IL-l (Genzyme Corp., Boston, Massachusetts, USA).
Cultures were maintained for 72 hours at 37°C in a 5% CO2 air
humidified atmosphere. Controls included cells alone, and cells
with IL-l alone or PHA alone. Cultures were pulsed with 0.5
tCi [3H] thymidine (Amersham International, Amersham,
Buckinghamshire, UK) for the final four hours of culture. Cells
were then collected onto filter paper with an automatic har-
vester(Titretek, Skatron A.A., Liebyen, Norway), dispersed in
toluene-based scintillant, and the [3H] thymidine activity
counted on a liquid scintillation counter (1210 Ultrabeta, LKB
Wallac, Turku, Finland). All assays were performed in tripli-
cate.
The IL- 1 content of unknown samples was determined by
comparing their ability to enhance [3H] thymidine incorporation
by thymocytes to a standard curve derived from the bioactivity
of known concentrations of IL-i (Genzyme). The mean en-
hancement of [3H] thymidine incorporation by IL-i (1.25 U/ml)
was 5939 1001 x i0 cpm (N = 11 assays). Uptake of [3H]
thymidine by thymocytes stimulated with PHA (1 g/ml) alone
was 829 110 cpm. Representative glomerular and macrophage
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supernatants were assayed in dilutions from I in 4 to 1 in 256 to
determine the concentration producing maximal [3H] thymidine
incorporation in thymocytes, and to minimize effects of poten-
tial inhibitors of IL-i bioactivity. Consequently, glomerular
supernatants were assayed at dilutions of I in 8 and I in 16, and
macrophage supernatants at dilutions of 1 in 4 and 1 in 8.
Similar final IL-l concentrations were obtained at these two
dilutions. Glomerular and macrophage supernatants in the
absence of PHA did not stimulate [3H] thymidine uptake by
thymocytes.
Using polyclonal anti-human IL-i antibody (Genzyme) at a
dose which resulted in 61% inhibition of bioactivity of cell-line-
derived human IL-l standard (10 U/ml), IL-l bioactivity of a
glomerular supernatant (10 UIml) was inhibited by 49%. Poly-
clonal anti-human platelet-derived growth factor (PDGF) immu-
noglobulin (Collaborative Research mc) at a dose producing
100% neutralization of the bioactivity of PDGF (5 sg/ml) failed
to inhibit the stimulation of thymocyte [3H1 thymidine incorpo-
ration induced by the same glomerular supernatant.
Endotoxin (LPS from E. co/i serotype 0l27B8, Sigma; 0.01
ng/ml to 5.0 g/ml), human recombinant tumor necrosis factor
n (TNF, Genzyme; 0.1 to 1.0 nglml) and human recombinant
PDGF (Amersham International; 1.0 and 5.0 ng/ml) failed to
cause any significant increase in [3H] thymidine incorporation
by PHA stimulated thymocytes.
Ge/filtration of glomeru/ar supernatants
Glomeruli from three rabbits with PAGBMGN were isolated,
pooled and cultured for 24 hours at a concentration of 1 x
104/ml in medium containing 1% FCS. The culture supernatant
was dialyzed against 100 mM NaC1, 50 mtvi Tris/HC1, pH 7.4,
0.01% polyethylene glycol 4000 (PEG, Merck, Schuchardt,
Munich, FRG) and concentrated x 15 using PEG 6000 and
Amicon YM-lO centrifugal concentrators (Amicon, Danvers,
Massachusetts, USA), at 4°C. The concentrated material was
applied to a 16 mm x 660 mm Sephacryl S-200 SF column
(Pharmacia, Uppsala, Sweden) equilibrated in the same buffer
and eluted at a flow rate of 15 ml/hr Fractions were assayed for
protein by measuring optical density at 280 mm and for IL-i
bioactivity as above. The column was calibrated by the use of
molecular weight markers (Pharmacia) and human cell line-
derived IL-i (Genzyme), which was detected by its bioactivity.
Quantitation of proteinuria
Rabbits were housed in metabolic cages to collect their urine
output over the final 24 hours of each experiment. Protein
concentrations were determined by the Bradford method [27].
Light transmission (595 nm wavelength) was measured using a
spectrophotometer (Milton Roy Corp, Rochester, New York,
USA) 10 minutes after the addition of 3 ml of 100 pg/ml Electran
Page blue in 5% ethanol/8. 1% orthophosphoric acid to 20 pJ of
each urine sample. Values were calculated from a standard
curve derived from bovine serum albumin.
Quantitation of glomeru/ar macrophages
Isolated nephritic glomeruli were cultured individually in
droplet culture [21, 23] for three days to determine the number
of macrophages emigrating onto the tissue culture flask per
glomerulus. The glomerular macrophage numbers determined
by this technique represent the mean of counts from a minimum
of 20 glomeruli per animal. These glomerular macrophage
counts correlate well with the estimation of glomerular macro-
phage numbers by histochemical staining [28].
Experimental design
New Zealand White rabbits between 2.0 and 2.5 kg in weight
were used for these experiments. The following groups were
studied:
PAGBMGN. This group consisted of seven rabbits in which
PAGBMGN was initiated as described previously. Glomerular
macrophages, alveolar macrophages and blood monocytes were
isolated from six animals in this group.
Leukocyte depleted PAGBMGN. Ten rabbits received total
body megavoltage gamma irradiation administered as a single
dose (6.5 Grays) with renal shielding. Shielding reduced the
computed renal dose of irradiation to <0.1% of the dose
received by other tissues. To confirm the efficacy of renal
shielding, the ability of isolated glomeruli from irradiated rab-
bits to release IL-I in response to LPS was assessed in vitro.
IL-i production by normal glomeruli was stimulated from 0.17
0.13 p1103 gloms/24 hr to 0.95 0.15 p1103 gloms/24 hr (N =
4) in the presence of 1 sg/m1 of LPS (Sigma). IL-i production
by glomeruli from irradiated rabbits with renal shielding was
stimulated from 0.22 0.12 to 0.74 0.47 U/b3 gloms/24 hr
with LPS (N = 5).
Irradiation produced leukopenia, with circulating leukocytes
less than 1000 cells/p1 in all animals after 10 days. At this time
rabbits were given PAGBMGN initiating antibodies as de-
scribed previously. Circulating leukocytes were also counted at
the end of the experimental protocol.
Hetero/ogous anti-GBM GN. Heterologous-phase GBM in-
jury was initiated as previously described. Seven rabbits were
sacrificed after 24 hours, and six after 44 hours.
Normals. Ten normal rabbits housed in metabolic cages for
24 hours prior to sacrifice were used as controls.
Statistics
Cell numbers, proteinuria and IL-i results represent the
mean SEM for each group. Statistical significance was ana-
lyzed by analysis of variance. For glomerular IL-i data and for
macrophage IL-i data (24-hr IL-i production), the hypothesis
that the group means were equal was rejected in both cases (P
<0,05). The least significant difference (LSD) was calculated to
compare group means. Macrophage IL-i production after one
hour was not significantly different between the three groups.
Results
Proteinuria and glomerular macrophage numbers
After 44 hours, rabbits with PAGBMGN and heterologous-
phase anti-GBM GN developed marked proteinuria (2257 444
mg124 hr and 3799 990 mg124 hr, respectively) compared to
normal rabbits (13.7 2.3 mg124 hr; Table 1). Macrophages
consistently accumulated in the glomeruli of rabbits with
PAGBMGN (43.8 13.3 macrophages per gbomerulus [macsi
glom]), but were only present in small numbers in the glomeruli
of rabbits with heterologous-phase anti-GBM GN (4.7 1.2
macs/glom at 24 hr and 0.8 0.4 macs/glom at 44 hr).
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Macrophages were only occasionally presented in glomeruli
from normal rabbits (0.3 0.2 gloms/mac).
Glomerular IL-I production in PAGBMGN
Glomerular supernatants from rabbits with PAGBMGN stim-
ulated [3HJ thymidine uptake by thymocytes in the presence of
PHA (Figs. I and 2). This thymocyte stimulating activity was
titratable over a range of supernatant dilutions from 1 in 8 to 1
in 256. Figure 1 shows a dilution response curve for a repre-
sentative glomerular supernatant. The slope of the line of best
fit was 0.91 (r = 0.98). This one to one relationship between
supernatant concentration and [3H} thymidine incorporation
has previously been suggested to be indicative of a single
mitogenic factor [6]. Glomeruli from animals with PAGBMGN
produced increasing quantities of IL-i bioactivity with time in
Fig. 2. The time course of interleukin I production by isolated cultured
glomeruli from normal rabbits (open circles) and rabbits with passive-
autologous anti-GBM GN (closed circles). (Me4n [3H1 thymidine incor-
poration in response to 1.25 U of IL-I was 9018 1067 cpm, PHA
control 775 103 cpm).
culture (Fig. 2). The IL-i concentrations in these culture
supernatants increased from 0.35 0.17 U/b3 gloms after one
hour to 0.39 0.25 U/103 gloms (4 hr) and 1.43 0.79 U/b3
gloms at 24 hours. The mean rate of IL-I production over the 24
hours in culture (0.06 U/b3 gloms/hr) was less than the IL-I
production in the first hour (0.35 U/b3 gloms/hr), indicating
that glomerular culture in itself did not induce glomerular IL-i
production. IL-i production by normal glomeruli was not
significantly greater after 24 hours in culture (0.13 0.06 U/tO3
gloms) than after one hour (0.03 0.02 U/103 gloms) or four
hours in culture (0.03 0.03 U/b3 gloms).
Isolated glomeruli from rabbits with PAGBMGN produced
significantly more IL-b (1.43 0.79 U/b3 gloms/24 hr) than
glomeruli from rabbits with heterologous phase injury or normal
animals (Fig. 3). Twenty-four hours after initiation of heterolo-
gous phase injury, IL-l production by isolated giomeruli was
0.11 0.07 U/b3 gloms/24 hr (P < 0.05 compared with
PAGBMGN) and after 44 hours, glomerular IL-i production
was 0.03 0.01 U/b3 gboms (1 hr culture), 0.06 0.02 U/103
gloms (4 hr culture) and 0.15 0.15 U/b3 gloms (24 hr culture,
P < 0.05 compared with PAGBMGN). Production of IL-i by
glomeruli from rabbits with heterobogous phase injury was not
significantly different from the IL-b production of normal gb-
meruli (0.13 0.06 U/i03 gloms/24 hr). There was a significant
linear correlation between gbomerular macrophage numbers and
glomerular IL-i production when the data for each individual
rabbit in these studies was pooled and analyzed by linear
regression (intercept 0.006, slope 2.30, r = 0.84, P = 0.005).
Irradiation produced severe leukopenia in all treated rabbits
(963 96 leukocytes/d). Their leukocyte numbers were signif-
icantly reduced when compared with untreated rabbits with
PAGBMGN (14,388 3,386 leukocytes/pi; P < 0.05). IL-i
Table 1. Proteinuria, glomerular macrophages and glomerular
interleukin 1 production
IL-i
Group N
Proteinuria
mg124 hr
Glomerular
macrophages
macsiglom
production
U/I0
gloms/24 hr
Normal 10 13.7 2.3 0.3 0.2 0.13 0.06
PAGBMGN 7 2257 444 43.8 13.3 1.43 0.79
Leukocyte
depleted 10 630 200 0.7 0.1 0.16 0.07
PAGBMGN
Heterologous-
phase anti-GBM GN
24 hours 7 786 179 4.7 1.2 0.11 0.07
44 hours 6 3799 990 0.8 0.4 0.15 0.15
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Fig. 1. Thymocyte [3H] thymidine incorporation above PHA control
induced by serial dilutions of glomerular supernatant from a rabbit with
PAGBMGN (r = 0.98).
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Fig. 3. The production of interleukin I by isolated glomeruli from
normal rabbits (normal), rabbits with passive autologous anti-GBM GN
(PAGBMGN), macrophage depleted rabbits with PAGBMGN (mac
deplete PAGBMGN) and rabbits with heterologous phase anti-GBM
GN (Heterol GN) after 24 hours and 44 hours. Mean [3H] thymidine
incorporation in response to 1.25 U of IL-i was 5667 1103 cpm, PHA
control 567 98 cpm.
production by isolated glomeruli from leukocyte depleted rab-
bits with PAGBMGN was 0.16 0.07 U/103 glomI24 hr. This
was significantly less than the IL-i production by glomeruli
from rabbits with PAGBMGN (P < 0.05), and no different from
IL-i production by normal glomeruli, indicating that glomerular
IL-i production in this model is macrophage dependent.
Molecular weight of IL-i bioactivity
IL-i bioactivity was eluted in two peaks from the Sephacryl
SF-200 column (Fig. 4). A narrow peak was detected corre-
sponding to a molecular weight of 16,500 daltons, and a broader
"dual" peak was also present with molecular weights corre-
sponding to 33,000 and 40,500 daltons. Human cell line-derived
IL-i bioactivity eluted in the same region as the low molecular
weight IL-i bioactivity from glomerular supernatants.
IL-I production by isolated glomerular macrophages
Isolated glomerular macrophages from rabbits with
PAGBMGN released more IL-i (0.66 0.38 U/b3 cells) than
PBM (0.16 0.06 U/b3 cells) or PAM (0.15 0.08 U/b3 cells)
from the same animals, after one hour in culture (Fig. 5). After
24 hours, IL-i production by glomerular macrophages (3.62
1.63 U/b3 cells/24 hr) was significantly greater than the IL-l
production by PAM (0.25 0.12 U/b3 cells/24 hr, P < 0.05)
and greater than IL-i production by PBM (0.51 0.30 ,JiO
cells/24 hr, P < 0.07) from the same animals. The amount of
IL-l produced by PBM and PAM was not significantly different.
Discussion
The current study demonstrates that glomeruli from rabbits
with experimental anti-GBM GN, where injury is macrophage
dependent, release "IL-i like" bioactivity. Supernatants from
macrophage infiltrated glomeruli produced titratable increases
in thymocyte [3H] thymidine uptake in a standard IL-i bioas-
say, which was shown to be insensitive to endotoxin, tumor
necrosis factor a and PDGF. The bioactivity of glomerular
supernatants could be substantially inhibited by a polyclonal
anti-human IL-i antibody, but no inhibition was observed using
an anti-PDGF antibody. The IL-i bioactivity was shown to
have a molecular weight of 16.5 kD on gel filtration chromatog-
raphy, consistent with previous reports for rabbit IL-i [2, 29].
The elution profile was similar to previously published data for
IL-i from human macrophages [7], endothelial cells [41 and lung
tissue [301, demonstrating high molecular weight peaks in
addition to a peak in the region of 15 to i8,000 kD. The high
molecular weight bioactivity has been variously attributed to
aggregates of IL-i with higher molecular weight proteins or
aggregates of IL-i itself [2].
Macrophage-infiltrated nephritic glomeruli from rabbits with
PAGBMGN produced increasing amounts of IL-i with time in
culture. After 24 hours in culture, IL-i production by nephritic
glomeruli was significantly greater than by normal glomeruli.
Glomerular culture per se did not induce IL-i production by
normal glomeruli or accelerate the IL-i production by nephritic
glomeruli.
Previous studies have highlighted the production of IL-i by
mesangial cells from normal glomeruli in vitro [5, 6, 8]. Produc-
tion of IL-l by these mesangial cells is dependent on their
proliferative rate, being maximal in their exponential growth
phase [311. In a non-proliferative, immune complex-initiated
model of GN in rats, total kidney mRNA for IL-i increased
two- to threefold over normal [19]. This suggests that mesangial
cells have a modest capacity to increase IL-i production in this
model of GN. In severe forms of human and experimental GN,
macrophages are predominant inflammatory cells and some
mesangial cell proliferation is present. Both macrophages and
mesangial cells therefore have the potential to contribute to
glomerular IL-i production in these proliferative forms of GN.
Demonstration of IL-i production by human umbilical endothe-
hal cells in culture [4] raises the possibility that glomerular
endothehial cells may also contribute to glomerular IL-i pro-
duction. The relative contributions of infiltrating macrophages
and intrinsic glomerular cells to IL-i production in GN have not
been directly assessed.
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Fig. 4. The mo/ecu/ar weight profile of IL-i
bioactivity (thymocyte co-stimulating activity,
•) in glomerular supernatant from rabbits
with PAGBMGN eluted from a Sephacryl SF-
200 column.
Øm
Glom PBM PAM
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Fig. 5. The production of interleukin 1 by glomerular macrophages
(glom macs), blood monocytes (PBM) and alveolar macrophages(PAM) from rabbits with passive autologous anti-GBM GN. Mean
[3H] thymidine incorporation in response to 1.25 U of IL-i was 7583
1216 cpm, PHA control 672 112 cpm.
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In the current studies, glomerular IL-i production was as-
sessed in two models of anti-GBM antibody induced GN.
Augmented glomerular IL-i production was associated with
GN in which glomerular macrophage infiltration was promi-
nent. Glomerular IL-i production showed an elevenfold in-
crease compared to normal. In macrophage independent GN,
where immune reactants including antibody, complement and
neutrophils are abundant within glomeruli, IL-l production was
not significantly increased compared to normal glomeruli. Thus,
despite GBM injury and the presence of immune reactants, IL-l
production by intrinsic glomerular cells was not measurably
increased in GN in the absence of macrophages. This suggests
in anti-GBM GN that the contribution of mesangial cells to
glomerular IL-i production is minor compared to the contribu-
tion of infiltrating glomerular macrophages.
Macrophage depletion studies were performed to more di-
rectly assess the role of macrophages in glomerular IL- 1 pro-
duction. Rabbits were irradiated to reduce circulating white cell
numbers to less than 1000 per M1 while shielding of their kidneys
avoided any effect on glomerular mesangial cells. After admin-
istration of disease initiating antibodies to these rabbits, gb-
merular macrophage numbers were less than 5% of the numbers
present in leukocyte intact rabbits with PAGBMGN, and gb-
merular IL- 1 production was not significantly increased above
normal. These studies demonstrate that macrophage infiltration
is essential for glomerular IL-l production in this model of GN.
Production of IL- 1 directly by gbomerular macrophages or
induction of IL-l release from intrinsic glomerular cells by
macrophage cytokines (or both) may explain the macrophage
dependence of glomerular IL- 1 production. Although IL-i
production by nephritic mesangial cells in vitro has previously
been demonstrated [181, release of IL-i by glomerular macro-
phages has not previously been reported.
To quantitate glomerular macrophage IL-l production, mac-
rophages were isolated from nephritic glomeruli by previously
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published techniques [22, 23] and their IL-i production over
short periods in culture was measured. Macrophages migrating
from glomeruli after one hour were studied to minimize the
possible changes in macrophage activation in vitro. Normal
rabbit glomeruli do not contain a resident macrophage popula-
tion and it has not been possible to isolate macrophages from
normal or heterologous phase nephritic glomeruli which could
serve as controls. These studies showed that glomerular mac-
rophages have markedly augmented IL-i production, compared
to other macrophage populations from the same rabbits, and
indicate that these macrophages are locally activated and di-
rectly contribute to glomerular IL-i production.
The IL-i production by isolated glomerular macrophages in
culture exceeded their IL-i production predicted from the
measured IL-i production of macrophage infiltrated intact
glomeruli. Several factors may contribute to an underestimation
of IL-i production by nephritic glomeruli in vitro. These may
include binding of IL-i to receptors of infiltrating or intrinsic
glomerular cells, absorption to glomerular constituents, inacti-
vation by inflammatory proteases within glomeruli, and physi-
cal limitations to diffusion. In addition, it is possible that the
glomerular macrophages isolated in these studies may represent
a more activated subpopulation of glomerular macrophages,
producing more IL-i than the population as a whole. These
studies suggest that macrophages are the predominant source of
glomerular IL-i, which is consistent with previous studies
showing that uninduced cortical macrophages from mice with
spontaneous GN contain 10 times more IL-l mRNA than
cultured mesangial cells from the same animals [19]. They do
not exclude the possibility that mesangial cells, or endothelial
cells under the influence of cytokines from infiltrating macro-
phages, may also contribute to glomerular IL-i production.
In summary, isolated glomeruli from rabbits with anti-GBM
GN exhibited augmented IL-I production which was macro-
phage dependent. Nephritic glomeruli from rabbits with mac-
rophage independent injury did not exhibit significantly in-
creased IL-i production. Macrophages isolated from IL-i
producing nephritic glomeruli were activated with regard to
their IL-i production. IL-i release from intraglomerular mac-
rophages may play a role in modulating mesangial cell prolifer-
ation and endothelial cell procoagulant expression in macro-
phage-associated proliferative forms of GN.
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